Moderna, Inc. : melts like snow in the sun
By Odile Dubois
Two years ago, the Cambridge-based biotech reached a market capitalization of $100 billion after developing a vaccine against Covid in record time.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132.9 USD | +0.17% | +13.29% | +33.63% |
May. 17 | Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing | MT |
May. 17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
By Odile Dubois
Two years ago, the Cambridge-based biotech reached a market capitalization of $100 billion after developing a vaccine against Covid in record time.
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
132.9 USD | +0.17% | +13.29% | 50.93B | ||
90.61 USD | -2.55% | -1.16% | 21.84B | ||
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |